When grown in serum-free media, GL261 cells express CD133, a stem cell marker, and have increased tumorgenicity18 and immunogenicity.14 Thus, GL261 cells can be used to investigate glioma stem cells, which contribute to chemo- and radioresistance in human GBM. This evidence concerns the gene PROM1 and glioblastoma.